{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T10:08:33Z","timestamp":1790071713648,"version":"4.0.1"},"reference-count":52,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Endocrinol."],"abstract":"<jats:p>Diabetic cardiomyopathy (DCM) is characterized by mitochondrial metabolic inflexibility, redox imbalance and defective organelle quality control, yet the endocrine program coordinating these abnormalities remains incompletely defined. Thyroid hormone (TH) is a major regulator of cardiac energy metabolism and mitochondrial adaptation. In experimental diabetes, myocardial triiodothyronine (T3) can decline despite preserved circulating thyroid hormone concentrations, accompanied by type 3 iodothyronine deiodinase (DIO3) induction and altered TH transport. We propose that this local defect disrupts thyroid hormone-mitochondrial coupling and may thereby constrain adaptation of substrate oxidation, oxidative phosphorylation, redox defense and organelle turnover. Preclinical diabetic-heart studies demonstrate local TH dysregulation and show that appropriately dosed T3 treatment can reverse selected structural and functional abnormalities. Complementary cardiac studies identify mitochondrial biogenesis, reactive oxygen species control, mitophagy and calcium handling as plausible downstream effectors. Together, these findings support impaired local TH signaling as an underrecognized candidate upstream mechanism linking the diabetic endocrine environment to mitochondrial maladaptation. A tissue-specific therapeutic-window model may reconcile the adverse consequences of both deficient and excessive TH signaling while providing a framework for biomarker development, mechanistic testing and precision intervention in DCM.<\/jats:p>","DOI":"10.3389\/fendo.2026.1987603","type":"journal-article","created":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:54:15Z","timestamp":1790070855000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":0,"title":["Disrupted thyroid hormone\u2013mitochondrial coupling in diabetic cardiomyopathy: a candidate upstream amplifier of metabolic and redox maladaptation"],"prefix":"10.3389","volume":"17","author":[{"given":"Yebin","family":"Xia","sequence":"first","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjie","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinjian","family":"Guo","sequence":"additional","affiliation":[{"name":"Department of Cardiology, The Second Affiliated Hospital of Fujian University of Traditional Chinese Medicine","place":["Fuzhou, Fujian, China"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,9,22]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"33","DOI":"10.4093\/dmj.2019.0185","article-title":"Mitochondrial mechanisms in diabetic cardiomyopathy","volume":"44","author":"Gollmer","year":"2020","journal-title":"Diabetes Metab J"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.1097\/CM9.0000000000003075","article-title":"Mitochondrial energy metabolism in diabetic cardiomyopathy: Physiological adaption, pathogenesis, and therapeutic targets","volume":"137","author":"Ye","year":"2024","journal-title":"Chin Med J (Engl)"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2026.119559","article-title":"Mitochondrial metabolic reprogramming in diabetic cardiomyopathy","volume":"200","author":"Zhou","year":"2026","journal-title":"BioMed Pharmacother"},{"key":"B4","doi-asserted-by":"publisher","first-page":"58","DOI":"10.1007\/s11892-020-01344-6","article-title":"Thyroid hormone signalling alteration in diabetic nephropathy and cardiomyopathy: A \u201cswitch\u201d to the foetal gene programme","volume":"20","author":"Mantzouratou","year":"2020","journal-title":"Curr Diabetes Rep"},{"key":"B5","doi-asserted-by":"publisher","DOI":"10.14814\/phy2.14858","article-title":"Thyroid hormones and the potential for regulating glucose metabolism in cardiomyocytes during insulin resistance and T2DM","volume":"9","author":"Mendez","year":"2021","journal-title":"Physiol Rep"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1515\/jbcpp-2024-0108","article-title":"The key roles of thyroid hormone in mitochondrial regulation, at interface of human health and disease","volume":"35","author":"Sagliocchi","year":"2024","journal-title":"J Basic Clin Physiol Pharmacol"},{"key":"B7","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1530\/acta.0.1230067","article-title":"Early changes in thyroid hormone metabolism in the heart, liver, and brown adipose tissue during the induction of low T3 syndrome in streptozotocin-diabetic rats","volume":"123","author":"G\u00f8tzsche","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"B8","doi-asserted-by":"publisher","DOI":"10.2119\/molmed.2013.00040","article-title":"Low-dose T3 replacement restores depressed cardiac T3 levels, preserves coronary microvasculature and attenuates cardiac dysfunction in experimental diabetes mellitus","volume":"20","author":"Weltman","year":"2014","journal-title":"Mol Med"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1016\/j.isci.2023.107826","article-title":"Thyroid hormone treatment counteracts cellular phenotypical remodeling in diabetic organs","volume":"26","author":"Lavecchia","year":"2023","journal-title":"iScience"},{"key":"B10","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/s12933-019-0814-4","article-title":"Early dysregulation of cardiac-specific microRNA-208a is linked to maladaptive cardiac remodelling in diabetic myocardium","volume":"18","author":"Rawal","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1210\/endo.143.7.8985","article-title":"Induction of thyroid hormone-degrading deiodinase in cardiac hypertrophy and failure","volume":"143","author":"Wassen","year":"2002","journal-title":"Endocrinology"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1210\/me.2011-1325","article-title":"Absence of myocardial thyroid hormone inactivating deiodinase results in restrictive cardiomyopathy in mice","volume":"26","author":"Ueta","year":"2012","journal-title":"Mol Endocrinol"},{"key":"B13","doi-asserted-by":"publisher","first-page":"2551","DOI":"10.1038\/s41467-020-16345-y","article-title":"FoxO1\u2013Dio2 signaling axis governs cardiomyocyte thyroid hormone metabolism and hypertrophic growth","volume":"11","author":"Ferdous","year":"2020","journal-title":"Nat Commun"},{"key":"B14","doi-asserted-by":"publisher","DOI":"10.3390\/ijms222111906","article-title":"Selenoprotein DIO2 is a regulator of mitochondrial function, morphology and UPRmt in human cardiomyocytes","volume":"22","author":"Bomer","year":"2021","journal-title":"Int J Mol Sci"},{"key":"B15","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.00483.2005","article-title":"Treatment of subclinical hypothyroidism reverses ischemia and prevents myocyte loss and progressive LV dysfunction in hamsters with dilated cardiomyopathy","volume":"289","author":"Khalife","year":"2005","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1016\/j.mce.2024.112254","article-title":"Exogenous thyroxine increases cardiac GLUT4 translocation in insulin resistant OLETF rats","volume":"590","author":"Mendez","year":"2024","journal-title":"Mol Cell Endocrinol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1016\/j.metabol.2013.05.008","article-title":"Thyroid hormone improves the mechanical performance of the post-infarcted diabetic myocardium: A response associated with up-regulation of akt\/mTOR and AMPK activation","volume":"62","author":"Mourouzis","year":"2013","journal-title":"Metabolism"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1016\/j.vph.2009.10.008","article-title":"Thyroid hormone and myocardial mitochondrial biogenesis","volume":"52","author":"Mar\u00edn-Garc\u00eda","year":"2010","journal-title":"VascPharmacol"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1111\/j.1582-4934.2010.01014.x","article-title":"Early long-term L-T3 replacement rescues mitochondria and prevents ischemic cardiac remodelling in rats","volume":"15","author":"Forini","year":"2011","journal-title":"J Cell Mol Med"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1007\/s00395-025-01106-z","article-title":"Triiodothyronine protects infarcted myocardium by reducing apoptosis and preserving mitochondria","volume":"120","author":"Cerullo","year":"2025","journal-title":"Basic Res Cardiol"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.53.5.1336","article-title":"Catalase protects cardiomyocyte function in models of type 1 and type 2 diabetes","volume":"53","author":"Ye","year":"2004","journal-title":"Diabetes"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.1016\/j.yexcr.2019.05.003","article-title":"Thyroid hormone protects cardiomyocytes from H2O2-induced oxidative stress via the PI3K-AKT signaling pathway","volume":"380","author":"Zeng","year":"2019","journal-title":"Exp Cell Res"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1210\/en.2016-1586","article-title":"N-acetylcysteine prevents low T3 syndrome and attenuates cardiac dysfunction in a male rat model of myocardial infarction","volume":"158","author":"Lehnen","year":"2017","journal-title":"Endocrinology"},{"key":"B24","doi-asserted-by":"publisher","DOI":"10.1210\/en.2014-1106","article-title":"Triiodothyronine prevents cardiac ischemia\/reperfusion mitochondrial impairment and cell loss by regulating miR30a\/p53 axis","volume":"155","author":"Forini","year":"2014","journal-title":"Endocrinology"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2019.109220","article-title":"Thyroid hormone postconditioning protects hearts from ischemia\/reperfusion through reinforcing mitophagy","volume":"118","author":"Bi","year":"2019","journal-title":"BioMed Pharmacother"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.3390\/cells12030396","article-title":"Effect of thyroxine on the structural and dynamic features of cardiac mitochondria and mitophagy in rats","volume":"12","author":"Venediktova","year":"2023","journal-title":"Cells"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbadis.2018.04.009","article-title":"Mst1 inhibits Sirt3 expression and contributes to diabetic cardiomyopathy through inhibiting parkin-dependent mitophagy","volume":"1865","author":"Wang","year":"2019","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.34133\/research.0001","article-title":"PGAM5-mediated PHB2 dephosphorylation contributes to diabetic cardiomyopathy by disrupting mitochondrial quality surveillance","volume":"2022","author":"Zou","year":"2022","journal-title":"Res (Wash D C)"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2023.102702","article-title":"BNP protects against diabetic cardiomyopathy by promoting Opa1-mediated mitochondrial fusion via activating the PKG-STAT3 pathway","volume":"62","author":"Chang","year":"2023","journal-title":"Redox Biol"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.2337\/db16-1237","article-title":"MICU1 alleviates diabetic cardiomyopathy through mitochondrial Ca2+\u2013dependent antioxidant response","volume":"66","author":"Ji","year":"2017","journal-title":"Diabetes"},{"key":"B31","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1186\/s12933-025-02801-w","article-title":"Acid sphingomyelinase promotes diabetic cardiomyopathy via disruption of mitochondrial calcium homeostasis","volume":"24","author":"Wei","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1016\/j.ceca.2025.103106","article-title":"Ablation of mitochondrial calcium uniporter alleviates cardiac dysfunction in type 1 diabetes","volume":"133","author":"Deb","year":"2026","journal-title":"Cell Calcium"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1152\/ajpendo.1983.244.6.E528","article-title":"Defective sarcoplasmic reticular calcium transport in diabetic cardiomyopathy","volume":"244","author":"Ganguly","year":"1983","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1139\/y84-099","article-title":"Lack of effect of thyroid hormone on diabetic rat heart function and biochemistry","volume":"62","author":"Tahiliani","year":"1984","journal-title":"Can J Physiol Pharmacol"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1152\/ajpheart.1988.254.2.H265","article-title":"T3 treatment does not prevent myocardial dysfunction in chronically diabetic rats","volume":"254","author":"Barbee","year":"1988","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1139\/y85-153","article-title":"Prevention of diabetes-induced myocardial dysfunction in rats by methyl palmoxirate and triiodothyronine treatment","volume":"63","author":"Tahiliani","year":"1985","journal-title":"Can J Physiol Pharmacol"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.1139\/y86-110","article-title":"Effects of triiodothyronine and carnitine therapy on myocardial dysfunction in diabetic rats","volume":"64","author":"Tahiliani","year":"1986","journal-title":"Can J Physiol Pharmacol"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.3390\/metabo13020308","article-title":"Divergent thyroid hormone levels in plasma and left ventricle of the heart in compensated and decompensated cardiac hypertrophy induced by chronic adrenergic stimulation in mice","volume":"13","author":"Simonides","year":"2023","journal-title":"Metabolites"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.3389\/fphys.2020.00729","article-title":"BNP as a new biomarker of cardiac thyroid hormone function","volume":"11","author":"Wang","year":"2020","journal-title":"Front Physiol"},{"key":"B40","doi-asserted-by":"publisher","first-page":"21865","DOI":"10.1038\/s41598-021-01454-5","article-title":"Low triiodothyronine levels correlate with high B-type natriuretic peptide levels in patients with heart failure","volume":"11","author":"Takahashi","year":"2021","journal-title":"Sci Rep"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1536\/ihj.16-477","article-title":"A low-normal free triiodothyronine level is associated with adverse prognosis in euthyroid patients with heart failure receiving cardiac resynchronization therapy","volume":"58","author":"Chen","year":"2017","journal-title":"Int Heart J"},{"key":"B42","doi-asserted-by":"publisher","DOI":"10.3389\/fcvm.2022.859608","article-title":"Value of FT3\/FT4 ratio in prognosis of patients with heart failure: A propensity-matched study","volume":"9","author":"Wang","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"B43","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCULATIONAHA.122.059631","article-title":"FGF21\u2013sirtuin 3 axis confers the protective effects of exercise against diabetic cardiomyopathy by governing mitochondrial integrity","volume":"146","author":"Jin","year":"2022","journal-title":"Circulation"},{"key":"B44","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.125.327867","article-title":"Mitochondrial STING governs glycolytic reprogramming in diabetic cardiomyopathy","volume":"139","author":"Zhang","year":"2026","journal-title":"Circ Res"},{"key":"B45","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2020.00256","article-title":"Icariin ameliorates diabetic cardiomyopathy through apelin\/Sirt3 signalling to improve mitochondrial dysfunction","volume":"11","author":"Ni","year":"2020","journal-title":"Front Pharmacol"},{"key":"B46","doi-asserted-by":"publisher","DOI":"10.1016\/j.redox.2021.102098","article-title":"Paeonol promotes Opa1-mediated mitochondrial fusion via activating the CK2\u03b1-Stat3 pathway in diabetic cardiomyopathy","volume":"46","author":"Liu","year":"2021","journal-title":"Redox Biol"},{"key":"B47","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jafc.9b05706","article-title":"Ginsenoside-Rb1 improved diabetic cardiomyopathy through regulating calcium signaling by alleviating protein O-GlcNAcylation","volume":"67","author":"Qin","year":"2019","journal-title":"J Agric Food Chem"},{"key":"B48","doi-asserted-by":"publisher","DOI":"10.1016\/j.ejphar.2024.176609","article-title":"Ginsenoside Rb1 ameliorates lipotoxicity-induced myocardial injury in diabetes mellitus by regulating Mfn2","volume":"974","author":"Ji","year":"2024","journal-title":"Eur J Pharmacol"},{"key":"B49","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2026.1829772","article-title":"Icariin attenuates diabetic cardiomyopathy by inhibiting NLRP3 inflammasome through SIRT3-mediated TFAM deacetylation","volume":"17","author":"Sun","year":"2026","journal-title":"Front Pharmacol"},{"key":"B50","doi-asserted-by":"publisher","DOI":"10.1016\/j.jep.2025.120667","article-title":"Icariin attenuates diabetic cardiomyopathy by activating Nrf2-dependent antioxidant and mitochondrial pathways: Integrative evidence from network pharmacology and experimental validation","volume":"355","author":"Zhang","year":"2026","journal-title":"J Ethnopharmacol"},{"key":"B51","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2025.1532565","article-title":"Therapeutic potential of traditional Chinese medicine in diabetic cardiomyopathy: a review","volume":"16","author":"Li","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"B52","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2025.107712","article-title":"Mitochondrial quality control: a promising target of traditional Chinese medicine in the treatment of cardiovascular disease","volume":"215","author":"Pan","year":"2025","journal-title":"Pharmacol Res"}],"container-title":["Frontiers in Endocrinology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1987603\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T09:54:16Z","timestamp":1790070856000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fendo.2026.1987603\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,9,22]]},"references-count":52,"alternative-id":["10.3389\/fendo.2026.1987603"],"URL":"https:\/\/doi.org\/10.3389\/fendo.2026.1987603","relation":{},"ISSN":["1664-2392"],"issn-type":[{"value":"1664-2392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,9,22]]},"article-number":"1987603"}}